share_log

Cybin | 6-K: Report of foreign private issuer (related to financial reporting)

Cybin | 6-K: Report of foreign private issuer (related to financial reporting)

Cybin | 6-K:外國發行人報告(業績相關)
美股SEC公告 ·  08/16 03:52

Moomoo AI 已提取核心訊息

Cybin Inc. (Cybin), a biotechnology company, announced the filing of Form 6-K with the U.S. Securities and Exchange Commission (SEC) for August 2024. The report, signed by CEO Doug Drysdale, includes details of the upcoming Annual and Special Meeting of Shareholders scheduled for August 27, 2024. Shareholders will vote on several key issues, including the appointment of Zeifmans LLP as the auditor, the election of directors, a proposed consolidation of common shares by a ratio of up to 50:1, amendments to the Equity Incentive Plan, the Amended and Restated Rights Plan, and amendments to common share purchase warrants. The meeting will be held virtually, and shareholders can attend and vote online. The management information circular provides comprehensive information on the matters to be voted on, including the background and qualifications of director nominees, and outlines the procedures for proxy voting and appointing proxyholders.
Cybin Inc. (Cybin), a biotechnology company, announced the filing of Form 6-K with the U.S. Securities and Exchange Commission (SEC) for August 2024. The report, signed by CEO Doug Drysdale, includes details of the upcoming Annual and Special Meeting of Shareholders scheduled for August 27, 2024. Shareholders will vote on several key issues, including the appointment of Zeifmans LLP as the auditor, the election of directors, a proposed consolidation of common shares by a ratio of up to 50:1, amendments to the Equity Incentive Plan, the Amended and Restated Rights Plan, and amendments to common share purchase warrants. The meeting will be held virtually, and shareholders can attend and vote online. The management information circular provides comprehensive information on the matters to be voted on, including the background and qualifications of director nominees, and outlines the procedures for proxy voting and appointing proxyholders.
生物技術公司Cybin Inc. (Cybin)宣佈提交2024年8月份6-K表格給美國證券交易所(SEC)。由CEO Doug Drysdale簽署的報告包括即將於2024年8月27日舉行的股東年度和特別會議的詳細信息。股東將對多個重要問題進行投票,包括任命Zeifmans LLP作爲核數師,選舉董事,提議以最高50:1的比例合併普通股,修正權益激勵計劃,修訂經修訂的權利計劃,以及修訂普通股購買認股權證。會議將以虛擬方式進行,並允許股東在線參加和投票。管理信息循環提供有關將要表決事項的全面信息,包括董事提名人的背景和資歷,並概述代理投票和委任代理持有人的程序。
生物技術公司Cybin Inc. (Cybin)宣佈提交2024年8月份6-K表格給美國證券交易所(SEC)。由CEO Doug Drysdale簽署的報告包括即將於2024年8月27日舉行的股東年度和特別會議的詳細信息。股東將對多個重要問題進行投票,包括任命Zeifmans LLP作爲核數師,選舉董事,提議以最高50:1的比例合併普通股,修正權益激勵計劃,修訂經修訂的權利計劃,以及修訂普通股購買認股權證。會議將以虛擬方式進行,並允許股東在線參加和投票。管理信息循環提供有關將要表決事項的全面信息,包括董事提名人的背景和資歷,並概述代理投票和委任代理持有人的程序。
声明:本內容僅用作提供資訊及教育之目的,不構成對任何特定投資或投資策略的推薦或認可。 更多信息